SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 1447.46 millions, down -72.00% for the March 2025 quarter as against Rs. 5169.62 millions during the year-ago period.Profit after Tax for the quarter ended March 2025 saw a decline of -55.55% from Rs. 4906.86 millions to Rs. 2180.89  millions.Operating profit Margin for the quarter ended March 2025 slipped to -90.53% as compared to 1584.58% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1447.46 5169.62 -72.00 5496.47 16725.66 -67.14 5496.47 16725.66 -67.14
Other Income 44.13 712.62 -93.81 812.75 882.95 -7.95 812.75 882.95 -7.95
PBIDT -90.53 1584.58 -105.71 683.35 3871.13 -82.35 683.35 3871.13 -82.35
Interest -267.57 29.50 -1007.02 29.18 1037.67 -97.19 29.18 1037.67 -97.19
PBDT 2335.84 5424.74 -56.94 2886.21 6743.44 -57.20 2886.21 6743.44 -57.20
Depreciation 74.37 195.49 -61.96 244.79 804.10 -69.56 244.79 804.10 -69.56
PBT 2261.47 5229.25 -56.75 2641.42 5939.34 -55.53 2641.42 5939.34 -55.53
TAX 80.58 322.39 -75.01 80.58 577.55 -86.05 80.58 577.55 -86.05
Deferred Tax -38.26 -108.43 -64.71 -38.26 -108.43 -64.71 -38.26 -108.43 -64.71
PAT 2180.89 4906.86 -55.55 2560.84 5361.79 -52.24 2560.84 5361.79 -52.24
Equity 687.44 672.12 2.28 687.44 672.12 2.28 687.44 672.12 2.28
PBIDTM(%) -6.25 30.65 -120.40 12.43 23.14 -46.28 12.43 23.14 -46.28

Ind-Swift Lab. Share Price

144.70 1.00 (0.70%)
16-Apr-2026 15:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 938.00
Lupin 2322.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×